Appen has upgraded guidance for 2019, underpinned by its core Relevance revenue and largely from existing customers. Figure Eight provides the extra potential in 2020.
Michael Gable of Fairmont Equities suggest Appen has now seen a bottom and any weakness from here is a buying opportunity.
Peter Switzer of the Switzer Report explains while he remains positive, but cautious, about stock markets in the next few months.
Home ownership has long been considered critical to building wealth in Australia. So, does it matter if young people are taking longer to get into the mortgage belt?
Pitt Street Research has interviewed AnteoTech CEO Derek Thomson about progress with its AnteoCoat technology.
Coca-Cola Amatil expects a return to growth in 2020 with both channel and product mix providing positive impetus to revenue.
October saw strong demand for Australian fixed income ETFs, while in the US, investment in passive equity ETFs has outstripped that in active ETFs for the first time.
A glance through the latest expert views and predictions about commodities. Guinea; iron ore; base metals; and coal in China.
A tighter focus on core leasing business has allowed EclipX Group to improve its balance sheet position while harnessing technology that is opening up untapped market opportunities.
Medical technology group HeraMED Limited has gone from strength to strength since listing on the ASX in December 2018.
